Talking Medicines logo — Revolutionizing Healthcare Marketing with AI-Powered Convers...

Talking Medicines

Revolutionizing Healthcare Marketing with AI-Powered Conversational Intelligence | NY Advertising Week Accelerate 2024

Founded 2013 United States Jersey City, United States 39 employees Venture round Total: $3.22M AI, Data Analytics +2

General Information

Company Name Talking Medicines
Founded Year 2013
Location United States Jersey City, United States
Employees 39
Industries AI, Data Analytics, Health Care +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Talking Medicines. To contact Talking Medicines, visit talkingmedicines.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Talking Medicines compare?

A PDF of Talking Medicines and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Talking Medicines soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Talking Medicines

Talking Medicines, **founded in 2013**, is a **revolutionary** player in the **healthcare marketing** sector, boasting achievements such as being the **Gold Winner of PM360's Trailblazer Awards** in the **AI & Data Analytics Category 2023**. This **Data Science company** leverages Advanced Data Science, Curated LLMs, and Artificial Intelligence to extract strategic intelligence from **HCP and Patient Conversational Data**. Their offering, the **natural language interface Drug-GPT**, has earned them the prestigious PM360 Artificial Intelligence/Data Analytics Award 2023. In their **latest funding round in February 2022**, Talking Medicines secured a significant **£1.50M Venture Round investment**. The investors in this round were **SIS Ventures, Scottish Enterprise, Tern PLC**, known for backing growing IoT companies, and **Mark Bamforth**. **Headquartered in the United States**, Talking Medicines has positioned itself as a key player transforming the healthcare marketing landscape through cutting-edge data analytics and AI.

Business keywords: Healthcare Marketing, Natural Language Processing, Social Intelligence Platform, Digital Health, Real World Data, Patient Engagement, Actionable Insights

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £1.50M 4
SIS Ventures, Scottish Enterprise +2
01 Feb 2022
Seed Round £1.10M 1
Tern PLC - we back growing IoT companies
04 Nov 2020
Seed Round £622.00K 2
SIS Ventures, Scottish Investment Bank
13 May 2019
Seed Round Undisclosed 1
Rob Dobson
28 Jun 2017

Talking Medicines Alternatives & Competitors

View All Alternatives
Talking Medicines vs
xCures
xCures United States

Right Patient, Right Treatment, Right Time.

Convertible Note
42 employees
AI, Biotechnology
Talking Medicines vs
MyndYou
MyndYou United States

MyndYou’s AI-enabled virtual assistant Eleanor helps healthcare organizations reach more patients &...

Series A
42 employees
AI, Digital Health
Talking Medicines vs
uMotif
uMotif United Kingdom

Engaged Patients. Better Trials.

Series B
82 employees
Data Analytics, Health Care

FAQ About Talking Medicines

Revolutionizing Healthcare Marketing with AI-Powered Conversational Intelligence | NY Advertising Week Accelerate 2024
Talking Medicines was founded in 2013.
Talking Medicines is headquartered in Jersey City, United States.
Talking Medicines operates in AI, Data Analytics, Health Care and Machine Learning. Its work centres on Healthcare Marketing, Natural Language Processing, Social Intelligence Platform and Digital Health.
Talking Medicines has approximately 39 employees.
Talking Medicines has completed 4 funding rounds, raising a total of $3.22M. The latest funding stage is Venture round.
Top alternatives and competitors to Talking Medicines include xCures, MyndYou, uMotif, LynxCare, Marigold Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Talking Medicines and xCures are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Talking Medicines, https://bouncewatch.com/company/talking-medicines, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes